Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The epigenomics revolution in myelodysplasia: a clinico-pathological perspective.

Pathology - 1 Oct 2011

Tan Peter T, Wei Andrew H

Abstract excerpt

Rapid advances in molecular technologies are continually re-shaping the way we view and understand the mechanisms driving oncogenesis. The last decade has witnessed unparalleled change in the biology and therapy of the myelodysplastic syndromes (MDS), a heterogeneous collection of clonal myeloid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Methylation
Share to DNA, Neoplasm
Share to Epigenomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to TET2 gene

Share to Mutation

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 21881538
DOI: 10.1097/PAT.0b013e32834a4061

Genes

TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21881538-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The epigenomics revolution in myelodysplasia: a clinico-pathological perspective.PMID 21881538Read ↗

Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolutionSemantic proximity Read ↗

The myelodysplastic syndrome as a prototypical epigenetic diseaseSemantic proximity Read ↗

Update on cytogenetic and molecular changes in myelodysplastic syndromes.Semantic proximity Read ↗

Genetics of myelodysplastic syndromes: new insights.Semantic proximity Read ↗

Epigenetic dysregulation in myelodysplastic syndromes.Semantic proximity Read ↗

Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions: Myelodysplastic Syndromes.Semantic proximity Read ↗

The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia.Semantic proximity Read ↗

Mutations in Epigenetic Modifiers in Myeloid Malignancies and the Prospect of Novel Epigenetic-Targeted TherapySemantic proximity Read ↗

Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.Semantic proximity Read ↗

Genome sequencing in myelodysplastic syndromes: can molecular mutations predict benefit from hypomethylating agent therapy?Semantic proximity Read ↗

Myelodysplastic Syndromes: A New Decade.Semantic proximity Read ↗

The Impact of Epigenetic Modifications in Myeloid MalignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.